Dean Kereiakes, MD
Interventional Cardiology · Cincinnati, OHNPI 1427025055
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $85,377 of the $138,721 with a category attached, or 61.5%. Shockwave Medical, Inc accounts for 71.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $32,660 and has fallen 72.9% since, to $8,854 in 2025. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $680.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$99K
- Edwards Lifesciences$25K
- Ancora Heart, Inc.$5K
- Boston Scientific$4K
- Medicure Pharma Inc.$2K
- Abbott$1K
- plus $2K from 12 others
Across 737 payments — averaging $4442.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.2M
- Boston Scientific$788K
- Edwards Lifesciences$642K
- Amgen$239K
- Novo Nordisk AS$209K
- Novartis$143K
- plus $71K from 9 others
What the payments were for
- Consulting fees$85,37762%
- Speaking & faculty fees$39,95429%
- Travel & lodging$6,9915%
- Food & beverage$6,3745%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 49 | $98,961 |
| Edwards Lifesciences | 62 | $25,054 |
| Ancora Heart, Inc. | 17 | $5,083 |
| Boston Scientific | 24 | $4,400 |
| Medicure Pharma Inc. | 1 | $1,500 |
| Abbott | 13 | $1,244 |
| Medtronic(2 entities) | 19 | $974 |
| Biotronik Inc. | 6 | $824 |
| Abiomed | 2 | $240 |
| Asahi Intecc USA, Inc. | 1 | $196 |
| Jenavalve Technology, Inc. | 1 | $122 |
| Lundbeck LLC | 2 | $44 |
| Amarin Pharma, Inc. | 2 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Amgen | 1 | $12 |
| Chiesi USA, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Bardy Diagnostics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascular Lithotripsy$61,662
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$37,300
- SYNERGY$2,275
- Acute cardiovascular care$1,500
- GENERAL - THERAPIES$973
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$594
- COREVALVE EVOLUT R$291
- CoreValve Evolut$287
- PERIPHERAL VASCULAR$196
- ABSORB$175
- XIENCE SIERRA$166
- Resolute$160
- RESOLUTE ONYX$160
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$158
- PORTICO$150
- Impella$150
- Watchman$125
- JenaValve Pericardial TAVR System$122
- Edwards SAPIEN 3 Transcatheter Heart Valve$116
How this compares
$138,721 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 39 | $26,663 |
| Praluent PenAlirocumab | 16 | $18,604 |
| EntrestoSacubitril/Valsartan | 22 | $16,066 |
| EliquisApixaban | 18 | $13,740 |
| Ezetimibe | 53 | $2,460 |
| Eplerenone | 23 | $1,470 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 23 | $1,222 |
| Rosuvastatin Calcium | 51 | $926 |
| Bisoprolol Fumarate | 28 | $792 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 12 | $640 |
| ClopidogrelClopidogrel Bisulfate | 31 | $525 |
| Atorvastatin Calcium | 48 | $450 |
| Minoxidil | 20 | $376 |
| Metoprolol Succinate | 20 | $305 |
| Losartan Potassium | 30 | $291 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Cincinnati
- Timothy HenryCincinnati$605K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
- Joseph ChooCincinnati$224K
- Ian SarembockCincinnati$98K
- Puvi SeshiahCincinnati$81K
- Raviteja GuddetiCincinnati$68K
- Satya ShreenivasCincinnati$47K
- Amer SayedCincinnati$31K
- Zaid AlirhayimCincinnati$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.